204 related articles for article (PubMed ID: 36074944)
1. Treatment strategies for low-risk papillary thyroid carcinoma: a position statement from the Thyroid Department of the Brazilian Society of Endocrinology and Metabolism (SBEM).
Ward LS; Scheffel RS; Hoff AO; Ferraz C; Vaisman F
Arch Endocrinol Metab; 2022 Sept 08; 66(4):522-532. PubMed ID: 36074944
[TBL] [Abstract][Full Text] [Related]
2. Outcomes of Papillary Thyroid Microcarcinoma Presenting with Palpable Lateral Lymphadenopathy.
Papachristos A; Do K; Tsang VH; Sywak M; Gill AJ; Sidhu S; Clifton-Bligh RJ; Glover A; Gild ML
Thyroid; 2022 Sep; 32(9):1086-1093. PubMed ID: 35703333
[No Abstract] [Full Text] [Related]
3. Impact of radioiodine therapy on recurrence and survival outcomes in intermediate-risk papillary thyroid carcinoma -A systematic review and meta-analysis.
Chandekar KR; Satapathy S; Bal C
Clin Endocrinol (Oxf); 2024 Feb; 100(2):181-191. PubMed ID: 38050454
[TBL] [Abstract][Full Text] [Related]
4. Robot-assisted Sistrunk's operation, total thyroidectomy, and neck dissection via a transaxillary and retroauricular (TARA) approach in papillary carcinoma arising in thyroglossal duct cyst and thyroid gland.
Byeon HK; Ban MJ; Lee JM; Ha JG; Kim ES; Koh YW; Choi EC
Ann Surg Oncol; 2012 Dec; 19(13):4259-61. PubMed ID: 23070784
[TBL] [Abstract][Full Text] [Related]
5. Thyroid lobectomy for papillary thyroid cancer: long-term follow-up study of 1,088 cases.
Matsuzu K; Sugino K; Masudo K; Nagahama M; Kitagawa W; Shibuya H; Ohkuwa K; Uruno T; Suzuki A; Magoshi S; Akaishi J; Masaki C; Kawano M; Suganuma N; Rino Y; Masuda M; Kameyama K; Takami H; Ito K
World J Surg; 2014 Jan; 38(1):68-79. PubMed ID: 24081532
[TBL] [Abstract][Full Text] [Related]
6. The outcomes and prognostic factors of patients who underwent reoperation for persistent/recurrent papillary thyroid carcinoma.
Sun W; Di L; Chen L; Li D; Wu Y; Xiang J; Zhou S; Sun T
BMC Surg; 2022 Nov; 22(1):374. PubMed ID: 36324095
[TBL] [Abstract][Full Text] [Related]
7. Is surgical resection without radioactive iodine treatment a safe alternative treatment for T1-2N1bM0 papillary thyroid carcinoma?
Fujiwara T; Yoshizawa A; Mizuta M; Tamaki H
Auris Nasus Larynx; 2021 Feb; 48(1):148-153. PubMed ID: 32718811
[TBL] [Abstract][Full Text] [Related]
8. Video-Assisted Thyroidectomy for Papillary Thyroid Carcinoma: Oncologic Outcome in Patients with Follow-Up ≥ 10 Years.
Bellantone R; Raffaelli M; De Crea C; Sessa L; Traini E; Princi P; Lombardi CP
World J Surg; 2018 Feb; 42(2):402-408. PubMed ID: 29238849
[TBL] [Abstract][Full Text] [Related]
9. De-differentiation of papillary thyroid carcinoma into squamous cell carcinoma in an elderly patient: A case report.
Thewjitcharoen Y; Krittiyawong S; Butadej S; Nakasatien S; Polchart S; Junyangdikul P; Kanchanapituk A; Himathongkam T
Medicine (Baltimore); 2020 Apr; 99(16):e19892. PubMed ID: 32312017
[TBL] [Abstract][Full Text] [Related]
10. Thyroidectomy for Papillary Thyroid Carcinoma.
Lo CY
Methods Mol Biol; 2022; 2534():39-56. PubMed ID: 35670967
[TBL] [Abstract][Full Text] [Related]
11. Contralateral papillary thyroid cancer at completion thyroidectomy has no impact on recurrence or survival after radioiodine treatment.
Grigsby PW; Reddy RM; Moley JF; Hall BL
Surgery; 2006 Dec; 140(6):1043-7; discussion 1047-9. PubMed ID: 17188155
[TBL] [Abstract][Full Text] [Related]
12. [Hemithyroidectomy or total thyroidectomy for low-risk papillary thyroid cancer? : Surgical criteria for primary and secondary choice of treatment in an interdisciplinary treatment concept].
Dralle H; Weber F; Machens A; Brandenburg T; Schmid KW; Führer-Sakel D
Chirurgie (Heidelb); 2023 Jan; 94(1):79-92. PubMed ID: 36121448
[TBL] [Abstract][Full Text] [Related]
13. Comparison of Lobectomy vs Total Thyroidectomy for Intermediate-Risk Papillary Thyroid Carcinoma With Lymph Node Metastasis.
Xu S; Huang H; Huang Y; Qian J; Wang X; Xu Z; Liu S; Liu J
JAMA Surg; 2023 Jan; 158(1):73-79. PubMed ID: 36449303
[TBL] [Abstract][Full Text] [Related]
14. Long-term clinical outcomes and prognostic factors for patients with papillary thyroid carcinoma with other organ invasions after adjuvant radioactive iodine.
Kawamoto T; Shikama N; Fukumori T; Hoshi M; Yamada T
Endocrine; 2023 Apr; 80(1):79-85. PubMed ID: 36367673
[TBL] [Abstract][Full Text] [Related]
15. The effects of surgery, radioiodine, and external radiation therapy on the clinical outcome of patients with differentiated thyroid carcinoma.
Tsang RW; Brierley JD; Simpson WJ; Panzarella T; Gospodarowicz MK; Sutcliffe SB
Cancer; 1998 Jan; 82(2):375-88. PubMed ID: 9445196
[TBL] [Abstract][Full Text] [Related]
16. Clinical response to radioactive iodine therapy for prophylactic central neck dissection is not superior to total thyroidectomy alone in cN0 patients with papillary thyroid cancer.
Lin B; Qiang W; Wenqi Z; Tianyu Y; Lina Z; Bin J
Nucl Med Commun; 2017 Dec; 38(12):1036-1040. PubMed ID: 28953211
[TBL] [Abstract][Full Text] [Related]
17. Trends in the Management of Localized Papillary Thyroid Carcinoma in the United States (2000-2018).
Pasqual E; Sosa JA; Chen Y; Schonfeld SJ; Berrington de González A; Kitahara CM
Thyroid; 2022 Apr; 32(4):397-410. PubMed ID: 35078347
[No Abstract] [Full Text] [Related]
18. Undetectable thyroglobulin after total thyroidectomy in patients with low- and intermediate-risk papillary thyroid cancer--is there a need for radioactive iodine therapy?
Ibrahimpasic T; Nixon IJ; Palmer FL; Whitcher MM; Tuttle RM; Shaha A; Patel SG; Shah JP; Ganly I
Surgery; 2012 Dec; 152(6):1096-105. PubMed ID: 23158181
[TBL] [Abstract][Full Text] [Related]
19. Excellent prognosis of patients with solitary T1N0M0 papillary thyroid carcinoma who underwent thyroidectomy and elective lymph node dissection without radioiodine therapy.
Ito Y; Masuoka H; Fukushima M; Inoue H; Kihara M; Tomoda C; Higashiyama T; Takamura Y; Kobayashi K; Miya A; Miyauchi A
World J Surg; 2010 Jun; 34(6):1285-90. PubMed ID: 20041244
[TBL] [Abstract][Full Text] [Related]
20. Clinical impact of radioactive iodine dose selection based on the number of metastatic lymph nodes in patients with papillary thyroid carcinoma: A multicenter retrospective cohort study.
Kwon SY; Kim MH; Kong E; Chong A; Yoo SW; Jeon S; Park SA; Kim DW; Kang SH; Choi JE; Ha JM; Jeong SY; Lee SW
Clin Endocrinol (Oxf); 2021 Dec; 95(6):901-908. PubMed ID: 34185324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
